HOME >> MEDICINE >> NEWS
Gene chip discovery may lead to individualized treatment for 5 hereditary liver diseases

CINCINNATI -- Researchers at Cincinnati Children's Hospital Medical Center have developed the first gene chip to use in the early diagnosis of at least five hereditary liver diseases, to detect genetic causes of jaundice in children and adults, and potentially to lead to personalized treatment options.

The chip, termed the "jaundice chip," is nearly 100 percent effective in the detection of the most common mutations in children with inherited causes of jaundice, according to a new Cincinnati Children's study in the January issue of the journal Gastroenterology.

"Other chips have been developed to assess drug metabolism," said Jorge Bezerra, MD, a pediatric gastroenterologist at Cincinnati Children's and the study's lead investigator. "This is the first chip in the world that has been customized to diagnose genetic mutations in patients with inherited types of liver diseases."

The chip uses a new technology that rapidly and accurately discloses the composition of several genes known to cause liver disease in children and adults. "The jaundice chip may also help us to discover whether subtle changes in these five genes that can cause devastating diseases in children may also modify the clinical course of other common liver diseases in adults,"said Mitchell Cohen, M.D., director of the division of gastroenterology hepatology and nutrition at Cincinnati Children's.

Jaundice is a yellowing of the eyes and skin caused by impairment in bile flow from the liver to the intestine. Impaired bile flow, or cholestasis, commonly known as jaundice, can lead to severe liver disease. In children, jaundice and cirrhosis are responsible for more than half of the need for liver transplantation.

Previous research on humans identified five genes responsible for inherited forms of jaundice, Until now, the broad array of causes of cholestasis including genetic, metabolic, inflammatory and drug- or toxin-induced disorders, created
'"/>

Contact: Jim Feuer
jim.feuer@cchmc.org
513-636-4656
Cincinnati Children's Hospital Medical Center
21-Dec-2006


Page: 1 2 3

Related medicine news :

1. Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics
2. Speeding fingertip discovery -- 20 years of protein info in 1 place
3. Major discovery raises prospect of better patient care by improving platelet life span
4. African scientists will train at Emory University in latest drug discovery techniques
5. More insight into Alzheimers disease with Stanford discovery of possible cause
6. Hope for significant new diabetes treatment in Stanford discovery
7. BC catalyst discovery promises faster, cheaper drug production
8. New sleep gene discovery wakes up scientists
9. Mouse model aids discovery of novel melanoma metastasis gene
10. Turning the tables on drug discovery
11. Landmark book commemorates centennial of discovery of Alzheimers disease

Post Your Comments:
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 Jury ... nation’s first trial involving a da Vinci lawsuit, ... case, the family of a man who allegedly died of ... more than $8 million in damages from Intuitive Surgical, Inc. ... its physician training program for the da Vinci Surgical System ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Nearly 50,000 ... Appeals (BVA) in fiscal year 2012, with even more—54,033—expected ... waiting longer for a decision as the agency reports ... which provides veterans disability appeal services. The ... Veterans Affairs. , Although the BVA received 49,611 cases ...
(Date:5/22/2013)... Ore. A new study shows there is a ... in American young children one that does not ... the United States, girls had higher levels of self-regulation ... control their behavior and impulses, follow directions, and persist ... performance and college completion, in past studies by Oregon ...
(Date:5/22/2013)... Los Angeles, CA (PRWEB) May 22, 2013 ... therapy4parents.com , hosted by Patricia O’Laughlin Psychotherapy in ... now seeing people of all ages as progression ... “Including children of all ages into parenting therapy ... Patricia O’Laughlin emphasizes. Patricia O’Laughlin Psychotherapy now specializes ...
(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2
(Date:5/22/2013)... NEW YORK , May 22, 2013  Ohr ... the development of novel therapeutics for unmet medical needs, ... Almenoff , M.D., Ph.D., to its Board of ... industry, working on early and late stage drug development. ... Almenoff join Ohr,s Board," said Dr. Irach Taraporewala, CEO ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... Ambit Biosciences Corporation (Nasdaq: AMBI ... quizartinib (AC220), a potent and selective FLT3 inhibitor, will ... Society of Clinical Oncology, held May 31 through June ... . Information about the abstracts, ... can be viewed online at http://abstracts2.asco.org/ . Abstract ...
Breaking Medicine Technology:Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 3
Cached News: